These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28865280)

  • 21. Thiazolidin-2-cyanamides derivatives as novel potent
    Zhou TS; Wei B; He M; Li YS; Wang YK; Wang SJ; Chen JW; Zhang HW; Cui ZN; Wang H
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1736-1742. PubMed ID: 32928007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, Molecular Docking and β-Glucuronidase Inhibitory Potential of Indole Base Oxadiazole Derivatives.
    Anouar EH; Moustapha ME; Taha M; Geesi MH; Farag ZR; Rahim F; Almandil NB; Farooq RK; Nawaz M; Mosaddik A
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30857263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2,5-Disubstituted thiadiazoles as potent β-glucuronidase inhibitors; Synthesis, in vitro and in silico studies.
    Taha M; Barak Almandil N; Rashid U; Ali M; Ibrahim M; Gollapalli M; Mosaddik A; Mohammed Khan K
    Bioorg Chem; 2019 Oct; 91():103126. PubMed ID: 31349116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a series of 5-phenyl-2-furan derivatives containing 1,3-thiazole moiety as potent Escherichia coli β-glucuronidase inhibitors.
    Zhou TS; He LL; He J; Yang ZK; Zhou ZY; Du AQ; Yu JB; Li YS; Wang SJ; Wei B; Cui ZN; Wang H
    Bioorg Chem; 2021 Nov; 116():105306. PubMed ID: 34521047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, β-glucuronidase inhibition and molecular docking studies of cyano-substituted bisindole hydrazone hybrids.
    Abid O; Imran S; Taha M; Ismail NH; Jamil W; Kashif SM; Khan KM; Yusoff J
    Mol Divers; 2021 May; 25(2):995-1009. PubMed ID: 32301032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 2-Aminopyrimidine Derivatives and Their Evaluation as
    Iqbal S; Shaikh NN; Khan KM; Kiran S; Naz S; Ul-Haq Z; Perveen S; Choudhary MI
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36431887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and study of the α-amylase inhibitory potential of thiadiazole quinoline derivatives.
    Taha M; Tariq Javid M; Imran S; Selvaraj M; Chigurupati S; Ullah H; Rahim F; Khan F; Islam Mohammad J; Mohammed Khan K
    Bioorg Chem; 2017 Oct; 74():179-186. PubMed ID: 28826047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of oxadiazole-coupled-thiadiazole derivatives as a potent β-glucuronidase inhibitors and their molecular docking study.
    Taha M; Imran S; Alomari M; Rahim F; Wadood A; Mosaddik A; Uddin N; Gollapalli M; Alqahtani MA; Bamarouf YA
    Bioorg Med Chem; 2019 Jul; 27(14):3145-3155. PubMed ID: 31196753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and β-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones.
    Khan KM; Saad SM; Shaikh NN; Hussain S; Fakhri MI; Perveen S; Taha M; Choudhary MI
    Bioorg Med Chem; 2014 Jul; 22(13):3449-54. PubMed ID: 24844756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: a new class of β-glucuronidase inhibitors and in silico studies.
    Zawawi NK; Taha M; Ahmat N; Wadood A; Ismail NH; Rahim F; Ali M; Abdullah N; Khan KM
    Bioorg Med Chem; 2015 Jul; 23(13):3119-25. PubMed ID: 26001340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of novel quinoline-based thiadiazole, evaluation of their antileishmanial potential and molecular docking studies.
    Almandil NB; Taha M; Rahim F; Wadood A; Imran S; Alqahtani MA; Bamarouf YA; Ibrahim M; Mosaddik A; Gollapalli M
    Bioorg Chem; 2019 Apr; 85():109-116. PubMed ID: 30605884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-pot synthesis of thioxo-tetrahydropyrimidine derivatives as potent β-glucuronidase inhibitor, biological evaluation, molecular docking and molecular dynamics studies.
    Iraji A; Nouri A; Edraki N; Pirhadi S; Khoshneviszadeh M; Khoshneviszadeh M
    Bioorg Med Chem; 2020 Apr; 28(7):115359. PubMed ID: 32098709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2,5-Disubstituted furan derivatives containing 1,3,4-thiadiazole moiety as potent α-glucosidase and E. coli β-glucuronidase inhibitors.
    Li YS; He M; Zhou TS; Wang Q; He L; Wang SJ; Hu B; Wei B; Wang H; Cui ZN
    Eur J Med Chem; 2021 Apr; 216():113322. PubMed ID: 33652353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Oxo-1,2,3,4-tetrahydropyrimidines Ethyl Esters as Potent β- Glucuronidase Inhibitors: One-pot Synthesis, In vitro and In silico Studies.
    Iqbal S; Shaikh NN; Khan KM; Naz S; Ul-Haq Z; Perveen S; Choudhary MI
    Med Chem; 2018; 14(8):818-830. PubMed ID: 29793412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and evaluation of 3-quinoline carboxylic acids as new inhibitors of protein kinase CK2.
    Syniugin AR; Ostrynska OV; Chekanov MO; Volynets GP; Starosyla SA; Bdzhola VG; Yarmoluk SM
    J Enzyme Inhib Med Chem; 2016; 31(sup4):160-169. PubMed ID: 27590574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of (thio)urea derivatives as potent
    Xu K; Ying L; Ying T; Wu Q; Du L; Yu Y; Ying Y; Wei B; Wang H; Yang Z
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2387415. PubMed ID: 39140677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of novel benzohydrazone-oxadiazole hybrids as β-glucuronidase inhibitors and molecular modeling studies.
    Taha M; Ismail NH; Imran S; Selvaraj M; Rahim A; Ali M; Siddiqui S; Rahim F; Khan KM
    Bioorg Med Chem; 2015 Dec; 23(23):7394-404. PubMed ID: 26526743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition potential of phenyl linked benzimidazole-triazolothiadiazole modular hybrids against β-glucuronidase and their interactions thereof.
    Taha M; Uddin N; Ali M; Anouar EH; Rahim F; Khan G; Farooq RK; Gollapalli M; Iqbal N; Farooq M; Khan KM
    Int J Biol Macromol; 2020 Oct; 161():355-363. PubMed ID: 32512086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: synthesis, biological evaluation and docking studies.
    Liu P; Niu Y; Wang C; Sun Q; Zhai Y; Yu J; Sun J; Xu F; Yan G; Huang W; Liang L; Xu P
    Eur J Med Chem; 2014 May; 79():413-21. PubMed ID: 24763262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of new quinoline derivatives as promising inhibitors of NTPDases: Synthesis, SAR analysis and molecular docking studies.
    Hayat K; Afzal S; Saeed A; Murtaza A; Ur Rahman S; Khan KM; Saeed A; Zaib S; Lecka J; Sévigny J; Iqbal J; Hassan A
    Bioorg Chem; 2019 Jun; 87():218-226. PubMed ID: 30903944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.